Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page gained new metadata entries: 2014 ( U.S. NIH Grant/Contract ), Melanoma, related topics:, and MedlinePlus Genetics. These additions expand funding context and link to related resources.
    Difference
    0.1%
    Check dated 2026-08-25T20:47:30.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    - The Conditions label 'Melanoma' is removed and the related topics entry 'MedlinePlus Genetics' is deleted, reducing visible context and external resource links for the study.
    Difference
    0.1%
    Check dated 2026-08-18T20:01:07.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added, replacing v3.6.4, signaling a platform update.
    Difference
    0.0%
    Check dated 2026-08-11T18:38:20.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays related topics: Melanoma and MedlinePlus Genetics, linking to broader melanoma resources for user context.
    Difference
    0.1%
    Check dated 2026-08-04T15:58:40.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision history now shows Revision: v3.6.4 as the current revision, replacing the prior v3.6.3. This update reflects an internal versioning change to the page and does not modify study data, eligibility criteria, or other user-facing content.
    Difference
    0.0%
    Check dated 2026-07-28T14:28:01.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.3, indicating a newer version of the page or its documentation is now in effect. The update appears to affect metadata rather than visible content.
    Difference
    0.0%
    Check dated 2026-06-30T01:11:52.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.